| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 01/03/2013 | US20130005724 Pyridino-pyridinone derivatives, preparation and therapeutic use thereof |
| 01/03/2013 | US20130005698 Pharmaceutical for preventing or treating an inner ear disorder |
| 01/03/2013 | US20130005692 Synergistic composition and method of retarding and ameliorating photo induced retinal damage and cataracts while ameliorating dry eye syndrome |
| 01/03/2013 | US20130005691 Esters for treatment of ocular inflammatory conditions |
| 01/03/2013 | US20130005687 Imidazolo-, oxazolo-, and thiazolopyrimidine modulators of trpv1 |
| 01/03/2013 | US20130005675 Quinolone compound and pharmaceutical composition |
| 01/03/2013 | US20130005665 Macrogol 15 hydroxystearate formulations |
| 01/03/2013 | US20130004977 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays |
| 01/03/2013 | US20130004651 Sustained drug release from body implants using nanoparticle-embedded polymeric coating materials |
| 01/03/2013 | US20130004596 Pharmaceutical composition for treating diabetes containing quamoclit angulata extract |
| 01/03/2013 | US20130004583 Cell homogenate from stem cells derived from growing deer antlers, a method of obtaining it and its use |
| 01/03/2013 | US20130004511 Composition comprising inhibitors of irs-1 and of vegf |
| 01/03/2013 | US20130004507 METHODS OF ADMINISTERING ANTI-TNFalpha ANTIBODIES |
| 01/03/2013 | US20130004493 Epithelial membrane protein-2 (emp2) and proliferative vitroretinopathy (pvr) |
| 01/03/2013 | US20130004486 Treatment of vascularized pigment epithelial detachment with anti-vegf therapy |
| 01/03/2013 | US20130004467 Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells |
| 01/03/2013 | US20130004465 Adherent cells from placenta and use of same in disease treatment |
| 01/03/2013 | CA2840568A1 Compositions, uses, and preparation of platelet lysates |
| 01/03/2013 | CA2840155A1 Esters for treatment of ocular inflammatory conditions |
| 01/03/2013 | CA2840152A1 Esters for treatment of ocular inflammatory conditions |
| 01/03/2013 | CA2840143A1 Composition comprising inhibitors of irs-1 and of vegf |
| 01/03/2013 | CA2838976A1 Dha and epa in the reduction of oxidative stress |
| 01/03/2013 | CA2827130A1 Toroidal pharmaceutical formulations |
| 01/02/2013 | EP2540828A1 Composition comprising inhibitors of IRS-1 and of VEGF |
| 01/02/2013 | EP2540299A1 Eye drops for treating eye infection containing levofloxacin, salt thereof or solvate of same, method for treating eye infection, levofloxacin, salt thereof or solvate of same, and utilization thereof |
| 01/02/2013 | EP2540292A1 DHA and EPA in the reduction of oxidative stress |
| 01/02/2013 | EP2539322A1 Inhibitors of beta-secretase |
| 01/02/2013 | EP2538965A1 Therapeutic compositions for the treatment of dry eye disease |
| 01/02/2013 | EP2538962A1 Use of transforming growth factor - beta 1 (tgf- 1) inhibitor peptides for the treatment of corneal fibrosis and/or haze |
| 01/02/2013 | EP2538934A1 Method of accelerating corneal wound healing |
| 01/02/2013 | EP2538929A2 Sustained delivery of therapeutic agents to an eye compartment |
| 01/02/2013 | CN102858331A Pharmaceutical compositions and therapeutic applications of a hydrocortisone derivative designated as deina |
| 01/02/2013 | CN102850456A Humanized monoclonal antibody of vascular endothelial growth factor as well as preparation method and application thereof |
| 01/02/2013 | CN102850436A Growth hormone releasing peptides |
| 01/02/2013 | CN102850324A Indole compounds |
| 01/02/2013 | CN102847154A Therapeutic uses of inhibitors of RTP801 |
| 01/02/2013 | CN102847121A Radix bupleuri and radix puerariae external-infection cold treating pill |
| 01/02/2013 | CN102847111A Tongli heat purging capsule |
| 01/02/2013 | CN102847092A Preparation process of integration-type novel formulation of Evodia rutaecarpa decoction and production method thereof |
| 01/02/2013 | CN102847090A Preparation process of integration-type novel formulation of Flos Inulae and hematite decoction and production method thereof |
| 01/02/2013 | CN102846964A Cochinchinese asparagus root tuber and radix ophiopogonis tablets with a function of eyesight improving |
| 01/02/2013 | CN102846949A Traditional Chinese medicinal liquor |
| 01/02/2013 | CN102846942A Medicine for treating glaucoma and a preparation method thereof |
| 01/02/2013 | CN102846908A Group of kidney-tonifying and Yang-supporting tablet |
| 01/02/2013 | CN102846878A Preparation technology and production method for an integrated new formulation of angelica peony wine |
| 01/02/2013 | CN102846876A Preparation technology and production method for an integrated new formulation of Wuqin wine |
| 01/02/2013 | CN102846851A Eyesight-improving care solution |
| 01/02/2013 | CN102846850A Eye care solution |
| 01/02/2013 | CN102846843A Traditional Chinese medicinal composition having visual fatigue alleviation function, and its preparation method |
| 01/02/2013 | CN102846834A Traditional Chinese medicine for treating tinnitus |
| 01/02/2013 | CN102846753A Preparation process of integration-type novel formulation of Radix Puerariae, Rhizoma Coptidis and Scutellaria baicalensis decoction and production method thereof |
| 01/02/2013 | CN102846598A Application of coumarin in preparing formation inhibitors of advanced glycation end products (AGEs) |
| 01/02/2013 | CN102846430A Health-care eyeshade |
| 01/02/2013 | CN102178644B Timolol maleate (TM) eye gel and preparation method thereof |
| 01/02/2013 | CN102153543B Maleate salts of a quinazoline derivative useful as an antiangiogenic agent |
| 01/02/2013 | CN102068426B New application of Ginkgolide B derivative in medicament preparation |
| 01/02/2013 | CN102058540B Azithromycin sustained-release microsphere and dry suspension, preparation method and application thereof |
| 01/02/2013 | CN101830889B 嘧啶衍生物 Pyrimidine derivatives |
| 01/02/2013 | CN101659659B Pyridine derivative and medical application thereof |
| 01/01/2013 | US8344003 2-pyridinecarboxamide derivatives |
| 01/01/2013 | US8343988 Inhibitors of histone deacetylase |
| 01/01/2013 | US8343942 Methods for treating interstitial cystitis |
| 01/01/2013 | US8343931 Methods of inhibiting photoreceptor apoptosis |
| 12/27/2012 | WO2012178083A1 Methods of treating chronic disorders with complement inhibitors |
| 12/27/2012 | WO2012121560A3 Composition for preventing or treating hearing loss |
| 12/27/2012 | US20120329990 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 12/27/2012 | US20120329879 Beta-adrenergic receptor agonists and uses thereof |
| 12/27/2012 | US20120329873 D-serine for the treatment of visual system disorders |
| 12/27/2012 | US20120329850 Methods for treating retinopathy with extended therapeutic effect |
| 12/27/2012 | US20120329844 Valsartan salts |
| 12/27/2012 | US20120329834 Compounds for the treatment of mitochondrial diseases |
| 12/27/2012 | US20120329818 Limk2 inhibitors, compositions comprising them, and methods of their use |
| 12/27/2012 | US20120329805 Preparations and methods for ameliorating or reducing presbyopia |
| 12/27/2012 | US20120329802 Metalloenzyme inhibitor compounds |
| 12/27/2012 | US20120329785 Novel kinase inhibitors |
| 12/27/2012 | US20120329780 Novel kinase inhibitors |
| 12/27/2012 | US20120329773 Bicyclic ring system substituted amide functionalised phenols as medicaments |
| 12/27/2012 | US20120329759 Formulations and methods for vascular permeability-related diseases or conditions |
| 12/27/2012 | US20120328721 Aloe vera sprout concentrate or extract having superior skin cell growth promotion, antioxidant, and anti-allergy effects |
| 12/27/2012 | US20120328718 Pharmaceutical compositions |
| 12/27/2012 | US20120328706 Polymer particle delivery compositions and methods of use |
| 12/27/2012 | US20120328702 Nanoparticle compositions |
| 12/27/2012 | US20120328687 Formulations of selective alpha-2 agonists and methods of use thereof |
| 12/27/2012 | US20120328661 Coumarin compounds as receptor modulators with therapeutic utility |
| 12/27/2012 | US20120328636 Kdr peptides and vaccines comprising the same |
| 12/27/2012 | US20120328635 Chaperonin 10 variants |
| 12/27/2012 | US20120328617 Method for inhibiting angiogenesis |
| 12/27/2012 | US20120328613 Humanized anti-factor d antibodies and uses thereof |
| 12/27/2012 | US20120328588 Compound preparation and its uses for prevention and treatment of hearing impairment |
| 12/27/2012 | US20120328580 Compounds that enhance atoh1 expression |
| 12/27/2012 | US20120328525 Nanoparticle compositions and components thereof |
| 12/27/2012 | CA2840270A1 Methods of treating chronic disorders with complement inhibitors |
| 12/26/2012 | EP2537831A1 Imidazole derivative |
| 12/26/2012 | EP2536729A1 Cyclobutane and methylcyclobutane derivatives as janus kinase inhibitors |
| 12/26/2012 | EP2536433A2 Epithelial membrane protein 2 (emp2) binding reagents and their therapeutic uses in ocular diseases |
| 12/26/2012 | CN1816536B Regulator of cannabinoid receptor |
| 12/26/2012 | CN102844317A Cyclobutane and methylcyclobutane derivatives as janus kinase inhibitors |
| 12/26/2012 | CN102844029A Beta-carbolines for use in the treatment of hearing loss and vertigo |
| 12/26/2012 | CN102838660A Small molecule polypeptides with function of inflammation immune reaction inhibition, and applications thereof |
| 12/26/2012 | CN102838546A Pyrazole derivatives as modulators of 5-ht2a serotonin receptor useful for treatment of disorders related thereto |